Monopar Therapeutics Inc (MNPR)
0.6258
+0.01
(+0.94%)
USD |
NASDAQ |
May 24, 16:00
0.6258
0.00 (0.00%)
After-Hours: 20:00
Monopar Therapeutics Cash from Operations (TTM): -7.243M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -7.243M |
December 31, 2023 | -7.858M |
September 30, 2023 | -7.614M |
June 30, 2023 | -7.823M |
March 31, 2023 | -7.032M |
December 31, 2022 | -7.229M |
September 30, 2022 | -7.959M |
June 30, 2022 | -7.752M |
March 31, 2022 | -7.847M |
December 31, 2021 | -7.317M |
September 30, 2021 | -6.526M |
June 30, 2021 | -5.885M |
March 31, 2021 | -5.475M |
Date | Value |
---|---|
December 31, 2020 | -4.662M |
September 30, 2020 | -4.090M |
June 30, 2020 | -3.403M |
March 31, 2020 | -3.147M |
December 31, 2019 | -3.018M |
September 30, 2019 | -2.868M |
June 30, 2019 | -2.854M |
March 31, 2019 | -2.868M |
December 31, 2018 | -2.680M |
September 30, 2018 | -2.977M |
June 30, 2018 | -3.573M |
March 31, 2018 | -3.125M |
December 31, 2017 | -2.628M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-7.959M
Minimum
Sep 2022
-2.854M
Maximum
Jun 2019
-5.880M
Average
-6.779M
Median
Cash from Operations (TTM) Benchmarks
Perspective Therapeutics Inc | -13.34M |
Electromed Inc | 5.577M |
Xtant Medical Holdings Inc | -13.02M |
Asensus Surgical Inc | -60.39M |
Myomo Inc | -7.602M |